InDex Pharmaceuticals Holding AB (publ) interim report January - September 2021

Corporate Breaking News

Home : InDex Pharmaceuticals Holding AB (publ) interim report January - September 2021

Nov 24 2021	InDex Pharmaceuticals Holding AB (publ) interim report January - September 2021
STOCKHOLM, Nov. 24, 2021 /PRNewswire/ -- "We have now several clinics activated in the phase III study CONCLUDE and look forward to enrol the first patient in the near term", says Peter Zerhouni, CEO of InDex Pharmaceuticals. "It was quite dramatic in September when the FDA updated their...


Source:https://www.prnewswire.com:443/news-releases/index-pharmaceuticals-holding-ab-publ-interim-report-january--september-2021-301431438.html

Related News
» Global Orphan Designated Drug Rare Disease Market Clinical Trials Development Report » Naked Wines launches GivingTuesday fundraiser for Latinos in wine